Health
BioVaxys Files Patent Application for Novel COVID-19 Diagnostic for T-Cell Immunity – IT Business Net
Vancouver, BC, Nov 2, 2020 – (ACN Newswire) – BioVaxys Technology Corp. (CSE: BIOV) (“BioVaxys” or “the Company”), a world leader in haptenized protein vaccine…
Vancouver, BC, Nov 2, 2020 – (ACN Newswire) – BioVaxys Technology Corp. (CSE: BIOV) (“BioVaxys” or “the Company”), a world leader in haptenized protein vaccine research and development, announced today that it has filed a Provisional Patent Application with the U.S. Patent and Trademark Office entitled METHOD AND KIT FOR DETECTION OF CELL MEDIATED IMMUNE RESPONSE related to the potential development of a diagnostic for evaluating the presence or absence of a T-cell immune response to SARS-CoV-2,…
-
General19 hours agoMan dies in daylight shooting in Sydney’s north-west
-
Noosa News21 hours agoWhy the Brisbane City Hall clock has fallen silent
-
Noosa News22 hours agoResident rushed to hospital with multiple burns as house engulfed in flames in Woodridge
-
General21 hours agoMurder trial begins for man accused of killing and burning David Collisson near Mudgee